Melanoma-intrinsic β-catenin signaling prevents T cell infiltration and anti-tumor immunity

Overview of attention for article published in Journal for Immunotherapy of Cancer, November 2014

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (53rd percentile)

Mentioned by

patent: 2 patents

Readers on

mendeley: 12 Mendeley

Summary Patents

So far, Altmetric has seen 2 patents that reference this research output.

REDUCING BETA-CATENIN EXPRESSION TO POTENTIATE IMMUNOTHERAPY

Application EP-3600423-A4

European Patent Office

BETA-CATENIN INHIBITORS IN CANCER IMMUNOTHERAPY

Application EP-3265179-A4

European Patent Office

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.